IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Trial record 1 of 9 for:
"Leiomyomatosis"
Surgery for Intravenous Leiomyomatosis (SIVL)
This study has been completed.
Sponsor:
Li Yang
Information provided by (Responsible Party):
Li Yang, General Hospital of Beijing PLA Military Region
ClinicalTrials.gov Identifier:
NCT01707862
First received: October 14, 2012
Last updated: October 15, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Intravenous leiomyomatosis (IVL) with intracardiac extension is a rare benign smooth muscle tumor. Reviewing literature, intracardiac extension of the IVL has been reported in at least 70 cases. Most are individual case reports. Surgical experience is not much. However, different opinion of surgical strategies remain controversial. The purpose of this report is to describe our experience of surgical management for the IVL with intracardiac extension.
| Condition |
|---|
| Leiomyomatosis |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Retrospective |
| Official Title: | Surgical Management of Intravenous Leiomyomatosis With Intracardiac Extension: Our Experience and Outcomes |
Resource links provided by NLM:
Further study details as provided by Li Yang, General Hospital of Beijing PLA Military Region:
| Enrollment: | 6 |
| Study Start Date: | March 1997 |
| Study Completion Date: | October 2012 |
| Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |
All patients underwent surgical management. Clinical data were obtained from medical reports. Following-up was made through email and telephone.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Senior) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
From March 1997 to June 2011, 6 women patients were admitted to our hospital with intravenous leiomyomatosis with intracardiac extension.
Criteria
Inclusion Criteria:
- Age more than 18 years.
- Tumor markers were all within normal limits.
- Patients underwent surgical management.
- Patients were followed-up for more than 12 months.
Exclusion Criteria:
-Tumor markers were all within abnormal limits
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01707862
Please refer to this study by its ClinicalTrials.gov identifier: NCT01707862
Locations
| China | |
| Institute of Cardiovascular Disease | |
| Beijing, China | |
Sponsors and Collaborators
Li Yang
Investigators
| Principal Investigator: | Genetal Hospital Beijing Military Region, First class | Institute of Cardiovascular Disease |
More Information
| Responsible Party: | Li Yang, Doctor, General Hospital of Beijing PLA Military Region |
| ClinicalTrials.gov Identifier: | NCT01707862 History of Changes |
| Other Study ID Numbers: |
GHBeijing-20121012 |
| Study First Received: | October 14, 2012 |
| Last Updated: | October 15, 2012 |
Keywords provided by Li Yang, General Hospital of Beijing PLA Military Region:
|
Intravenous leiomyomatosis Surgery Smooth muscle tumor |
Additional relevant MeSH terms:
|
Leiomyomatosis Leiomyoma Neoplasms, Muscle Tissue |
Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms |
ClinicalTrials.gov processed this record on July 14, 2017